MG
AUPH icon

Michael Gelband’s Aurinia Pharmaceuticals AUPH Stock Holding History

Michael Gelband’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76M Buy
+221,620
New +$3.54M 0.02% 595
2025
Q4 		– Sell
-72,462
Closed -$801K – 1539
2025
Q3 		$801K Sell
72,462
-57,723
-44% -$630K 0.01% 1039
2025
Q2 		$1.1M Buy
130,185
+73,685
+130% +$591K 0.01% 926
2025
Q1 		$454K Buy
56,500
+3,000
+6% +$24.3K ﹤0.01% 1127
2024
Q4 		$480K Buy
+53,500
New +$437K ﹤0.01% 1166
2023
Q4 		– Sell
-345,814
Closed -$2.69M – 1465
2023
Q3 		$2.69M Buy
345,814
+297,782
+620% +$2.91M 0.03% 580
2023
Q2 		$465K Buy
48,032
+8,354
+21% +$86.7K ﹤0.01% 1387
2023
Q1 		$435K Buy
39,678
+3,156
+9% +$27.8K ﹤0.01% 1372
2022
Q4 		$158K Buy
+36,522
New +$212K ﹤0.01% 1486
2022
Q3 		– Sell
-180,472
Closed -$1.81M – 1863
2022
Q2 		$1.81M Buy
180,472
+26,148
+17% +$292K 0.02% 820
2022
Q1 		$1.91M Buy
154,324
+6,525
+4% +$101K 0.02% 803
2021
Q4 		$3.38M Buy
+147,799
New +$3.5M 0.04% 564
2021
Q2 		– Sell
-11,336
Closed -$147K – 2328
2021
Q1 		$147K Buy
+11,336
New +$164K ﹤0.01% 1923
2020
Q4 		– Sell
-21,988
Closed -$324K – 1951
2020
Q3 		$324K Buy
+21,988
New +$319K 0.01% 1244
2019
Q4 		– Sell
-28,400
Closed -$152K – 1517
2019
Q3 		$152K Buy
+28,400
New +$172K 0.01% 1181

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's AUPH Position: Q2 2026 in Review

Michael Gelband opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 221,620 shares worth $3.76M. The stake represents 0.02% of the portfolio and ranks #595 among its holdings. This is a return to the name: Michael Gelband previously reported a position in AUPH as recently as Q3 2025.

Michael Gelband first reported a position in AUPH in Q3 2019 and has held it in 15 quarters since. 279 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Michael Gelband held 221,620 shares of Aurinia Pharmaceuticals worth $3.76M as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Michael Gelband position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #595 holding.
  • Michael Gelband first reported a position in Aurinia Pharmaceuticals in Q3 2019 and has held it in 15 quarters since.
  • 279 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.